A recombinant mimetics of the HIV-1 gp41 prehairpin fusion intermediate fused with human IgG Fc fragment elicits neutralizing antibody response in the vaccinated mice
Authors:
- Xueqing XuXueqing Xu
- Shuwen LiuShuwen Liu
- Shibo JiangSJShibo Jiang
- 1 July 2010
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 398 (3) , 506-512
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- HIV Vaccine Research: The Way ForwardScience, 2008
- One Step Forward, Two Steps Back — Will There Ever Be an AIDS Vaccine?New England Journal of Medicine, 2007
- GP120: Target for Neutralizing HIV-1 AntibodiesAnnual Review of Immunology, 2006
- Placebo‐Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV‐1 InfectionThe Journal of Infectious Diseases, 2005
- Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal AntibodiesJournal of Virology, 2004
- Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41Journal of Virology, 2001
- Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug targetProceedings of the National Academy of Sciences, 1998
- Atomic structure of the ectodomain from HIV-1 gp41Nature, 1997
- Core Structure of gp41 from the HIV Envelope GlycoproteinCell, 1997
- A trimeric structural domain of the HIV-1 transmembrane glycoproteinNature Structural & Molecular Biology, 1995